17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
California’s 2019 legislative session recently ended, leaving employers with a number of new laws r...
Read More >
Companies No Longer Required to Pay Social Security Contributions for Independent Contractors - New...
Read More >
Wildfires pose an increasingly serious threat to the public and environment in California. So it sho...
Read More >
The UK’s Equality and Human Rights Commission (EHRC) has issued technical guidance setting out a de...
Read More >
One of the most controversial taxes of the Affordable Care Act (ACA) is in danger of repeal. The tax...
Read More >
On March 31, seven Bay Area counties issued stricter shelter-in-place orders and extended their effe...
Read More >